文献速递急性肾损伤慢性肾脏病

肾科门诊患者急性肾损伤后肾衰竭风险预测

Predicting kidney failure risk after acute kidney injury among people receiving nephrology clinic care.
PubMed 文献 · Nephrol Dial Transplant · 2020-01-01

这项在加拿大不列颠哥伦比亚省开展的观察性队列研究纳入7491例2003-09年转诊肾科门诊的患者,随访至2016年。既往AKI与肾衰竭(33.1% vs 26.3%)和死亡(23.8% vs 16.8%)风险增加相关(P<0.001)。将AKI纳入重新拟合的肾衰竭预测模型未改善预测能力(ROC比较P=0.16),原始KFRE在此人群中校准不佳且低估风险。

要点

  • 肾科门诊患者既往AKI与肾衰竭和死亡风险增加独立相关。
  • 在eGFR≥30 mL/min/1.73 m2者中AKI与肾衰竭风险增加独立相关(HR 1.35)。
  • 将AKI加入预测模型未改善肾衰竭预测,但AKI与死亡风险增加相关需重视。

核心结论

  • 在已接受肾科门诊护理的人群中,既往AKI与较差的长期预后相关。
  • AKI可能不改变肾衰竭风险预测,但忽视AKI对死亡风险的影响过于简单化。
  • 肾脏疾病患者面临除肾衰竭外的其他风险,个体结局的复杂性和变异性很重要。

研究设计与样本

  • 观察性队列研究,纳入2003-09年加拿大不列颠哥伦比亚省转诊肾科门诊的7491人,随访至2016年。
  • 预测因素为既往KDIGO定义的AKI、年龄、性别、蛋白尿、eGFR和肾脏诊断。
  • 结局为5年肾衰竭和死亡,构建病因特异性Cox模型并按eGFR(<30或≥30 mL/min/1.73 m2)分层。
  • 比较原始5年KFRE与两个重新拟合模型(含或不含AKI作为预测因子)的预测性能。

主要发现

  • AKI与肾衰竭风险增加相关(33.1% vs 26.3%)和死亡风险增加相关(23.8% vs 16.8%)(P<0.001)。
  • 在eGFR≥30 mL/min/1.73 m2者中,AKI与肾衰竭风险独立相关(HR 1.35,95%CI 1.07-1.70)。
  • 在eGFR<30 mL/min/1.73 m2者中,AKI与肾衰竭风险无独立关联(HR 1.05,95%CI 0.91-1.21)。
  • AKI与死亡风险增加在eGFR≥30者(HR 1.89,95%CI 1.56-2.30)和eGFR<30者(HR 1.43,95%CI 1.16-1.75)中均独立相关。
  • 将AKI纳入重新拟合的肾衰竭预测模型未改善预测(ROC比较P=0.16),决策曲线分析亦未显示改善。

临床怎么用

  • 在肾科门诊患者中,应认识到既往AKI提示肾衰竭和死亡风险增加。
  • 使用KFRE预测肾衰竭风险时需注意其在此人群中可能低估风险。
  • 评估AKI患者预后时需综合考虑肾衰竭和死亡风险,而非仅关注肾衰竭。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Outcomes after acute kidney injury (AKI) are well described, but not for those already under nephrology clinic care. This is where discussions about kidney failure risk are commonplace. We evaluated whether the established kidney failure risk equation (KFRE) should account for previous AKI episodes when used in this setting. METHODS: This observational cohort study included 7491 people referred for nephrology clinic care in British Columbia in 2003-09 followed to 2016. Predictors were previous Kidney Disease: Improving Global Outcomes-based AKI, age, sex, proteinuria, estimated glomerular filtration rate (eGFR) and renal diagnosis. Outcomes were 5-year kidney failure and death. We developed cause-specific Cox models (AKI versus no AKI) for kidney failure and death, stratified by eGFR (</≥30 mL/min/1.73 m2). We also compared prediction models comparing the 5-year KFRE with two refitted models, one with and one without AKI as a predictor. RESULTS: AKI was associated with increased kidney failure (33.1% versus 26.3%) and death (23.8% versus 16.8%) (P < 0.001). In Cox models, AKI was independently associated with increased kidney failure in those with an eGFR ≥30 mL/min/1.73 m2 {hazard ratio [HR] 1.35 [95% confidence interval (CI) 1.07-1.70]}, no increase in those with eGFR <30 mL/min/1.73 m2 ([HR 1.05 95% CI 0.91-1.21)] and increased mortality in both subgroups [respective HRs 1.89 (95% CI 1.56-2.30) and 1.43 (1.16-1.75)]. Incorporating AKI into a refitted kidney failure prediction model did not improve predictions on comparison of receiver operating characteristics (P = 0.16) or decision curve analysis. The original KFRE calibrated poorly in this setting, underpredicting risk. CONCLUSIONS: AKI carries a poorer long-term prognosis among those already under nephrology care. AKI may not alter kidney failure risk predictions, but the use of prediction models without appreciating the full impact of AKI, including increased mortality, would be simplistic. People with kidney diseases have risks beyond simply kidney failure. This complexity and variability of outcomes of individuals is important.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Sawhney S, Beaulieu M, Black C, et al. Predicting kidney failure risk after acute kidney injury among people receiving nephrology clinic care. Nephrol Dial Transplant. 2020. PMID: 30325464. doi:10.1093/ndt/gfy294

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。